AntlerA Competitors and Similar CompaniesClear all
BioCryst Pharmaceuticals's competitors and similar companies include Assertio.
 BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. | |
Founding Date | Founding Date 1986 | Founding Date 1995 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Durham, US HQ Hoover, US | Locations Lake Forest, US HQ |
Employees | Employees 14040% increase | Employees 3058% increase |
Valuation ($) | Valuation ($) 1.7 b | Valuation ($) 104.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $118.7m (FY, 2025) |
Net income | Net income $263.9m (FY, 2025) | Net income ($30.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 1.9m | Total funding raised $ 42.5m |
For sources of this data, please see the company profile
View Company Profiles
Assertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View company